The Venture Capital Method approaches valuation like a chess player thinking several moves ahead. Instead of wrestling with absent cash flows, the process starts at the projected exit event and works backward to today’s investment decision.
The logic is elegantly simple: if you believe a startup will sell for $100 million in five years, and you need a 10x return to account for risk, then today’s pre-money valuation would be about $10 million. Of course, assumptions drive the results.
The three-step process looks like this:
First, anchor to a terminal value using comparable companies or recent acquisitions. For example, AI infrastructure startups commanded 12x – 18x forward revenue multiples in 2023-2024, based on PitchBook data. This becomes the reference point, although market multiples can change with broader trends.
Next, set a target return on investment. Early-stage VCs often seek 10x – 30x returns because most startups fail. The small number of winners balance out the losses. Series A rounds frequently price companies at around one-tenth of their plausible exit value.
Finally, the present value calculation uses this formula:
Pre-Money Valuation = Terminal Value / (1 + Target ROI)years to exit
But intellectual honesty matters most here. Exit multiples are not fixed. Median tech IPO valuations dropped 40% from 2021 to 2023, according to Goldman Sachs research. Companies trading at 20x revenue can quickly become outdated if interest rates rise.
Market timing assumptions also add uncertainty. Assuming a five-year exit excludes variables like liquidity droughts and shifting macro cycles. VC exit volume in Q1 2024, for example, was down 28% year-over-year (Bain & Company). There will be times when exits take far longer than planned.
Dave Berkus tackled a major issue: how do you value a company that’s early-stage, often with little more than an idea? His answer was to assign dollar values to progress milestones that lower startup risk.
The Berkus Method identifies five key drivers, each worth $500,000 to $2 million in pre-money valuation:
For example, a quantum computing startup with a working prototype and IEEE-published research secured a $1.8 million pre-money valuation—$1.2 million credited to validated technology, $600,000 to the technical team.
Angel investors favor this approach for its simplicity. Each milestone achieved reduces risk and justifies a higher valuation.
However, subjectivity remains. A Stanford study found that different angel investors had a 63% variance when valuing the same milestones. Definitions are vague: what qualifies as a “strategic partnership”? A simple pilot program or a formal agreement with a tech giant?
A bigger issue is that the method rewards execution without judging direction. For example, hardware startups might achieve technical milestones, but 42% had to pivot after their first prototype in 2023 (Crunchbase). Large portions of value could accumulate for building something with little market demand.
Bill Payne’s Scorecard Method uses a different approach. Instead of forecasting exit values or milestone checks, it starts with the regional median pre-money valuation, then tweaks that number based on company-specific assessments.
The formula:
Adjusted Valuation = Regional Median Pre-Money × Sum of Factor Adjustments
Typical weighting:
| Factor | Weight | Adjustment Range |
|---|---|---|
| Management Team | 30% | ±25% |
| Market Opportunity | 25% | ±20% |
| Technology/IP | 15% | ±15% |
| Competitive Environment | 10% | ±10% |
| Sales/Marketing | 10% | ±10% |
| Funding Requirements | 10% | ±5% |
A Berlin biotech startup demonstrates this in practice. Starting with a €3.7 million median, it gained a 20% premium (Nobel laureate co-founder), but regulatory hurdles deducted 15%. Final: €4.3 million pre-money.The scorecard’s strength is its anchoring in actual market data. Founders know what investors are paying for similar companies. This grounds expectations and keeps valuations from swinging wildly based on hype or pessimism.
On the flip side, regional biases can be problematic. For example, Silicon Valley medians are 2.1x higher than European ones, per Dealroom. A standout startup in Prague might end up valued less than an average peer in California, just because of geography.
Likewise, market timing impacts the data. In the 2023 generative AI bubble, “technology” weights increased by 34% on average (McKinsey), leading to temporarily inflated benchmarks.
The Venture Capital Method works best for institutional funding rounds where investors perform detailed due diligence. Investment committees prefer the discipline of this approach, but reliance on exit multiples can be risky if markets shift quickly.
The Berkus Method is ideal for pre-seed and angel funding rounds when quick decisions are required. In a short pitch meeting, assigning values to milestones is practical. However, its speed comes at the cost of subjectivity—which sophisticated investors may potentially exploit.
The Scorecard Method is well-suited to funding for geographic expansion, especially for startups entering new markets or countries. Calibrating expectations using local benchmarks is valuable, but gathering reliable market data can be time-consuming.
| Method | Best Use Case | Speed | Primary Risk |
|---|---|---|---|
| Venture Capital | Institutional Rounds | Moderate | Exit Multiple Volatility |
| Berkus | Pre-Seed/Angel Deals | Fast | Milestone Subjectivity |
| Scorecard | Geographic Expansion | Slow | Benchmark Staleness |
In a bull case, such as a low-interest-rate environment with abundant IPOs, the Venture Capital Method becomes more accurate as comparable multiples stabilize. Deeptech startups with strong technical proof can see premiums of 20 – 30%, according to Morgan Stanley.
In contrast, a bear case, such as ongoing inflation, raises scrutiny on Berkus milestones. Investors may demand actual paying customers as proof of early traction, rather than just waitlist signups. The Scorecard Method can also falter, as benchmark data often lags behind new market realities by six months or more (BlackRock).
Triangulation is often best, given current market uncertainty. One climate-tech startup combined VC, Berkus, and Scorecard approaches, pitching a valuation range and ultimately securing terms 8% above peer deals (TechCrunch). Presenting a range is frequently more credible than providing a single-point valuation.
Valuing early-stage companies is best viewed as probabilistic reasoning with incomplete data. Each of these methods – the VC Method for analytical rigor, the Berkus Method for practical adaptability, and the Scorecard for market grounding – offers different perspectives.
It’s important to treat ranges as more meaningful than single numbers. Modeling scenarios — best case, base case, downside — gives a clearer view of risks and opportunities. Consider applying a 15 – 30% liquidity discount for minority stakes.
Most importantly, keep in mind the realistic limits of these approaches. When cash flows are missing and business models are evolving, it’s necessary to make decisions with humility and recognize the level of uncertainty involved.
Effective startup valuation frameworks help calibrate investment confidence to the available evidence and realistic assumptions.
In summary, no single valuation method can capture every nuance of an early-stage venture. By leveraging the analytical depth of the Venture Capital Method, the milestone focus of the Berkus Method, and the market anchoring of the Scorecard Method, investors and founders can assemble a more balanced and credible valuation narrative. Stress-testing assumptions across bull and bear scenarios, framing valuations as ranges, and applying appropriate discounts for liquidity or minority stakes further refines decision-making. Ultimately, embracing probabilistic reasoning and acknowledging inherent uncertainties fosters more realistic expectations and strengthens investment discipline.
